Dr. Joanie Mayer Hope

Board Certified Gynecologic Oncologist, Dr. Joanie Mayer Hope is the founder and managing partner of Alaska Women’s Cancer Care.
Based in Anchorage, Dr. Mayer Hope manages the surgical and chemotherapeutic aspects of women’s cancer treatment. Dr. Mayer Hope is the Director of Gyn Oncology at Providence Alaska Cancer Center and the Alaska Native Medical Center and also operates at Alaska Regional Hospital in Anchorage. By integrating care in these centers, she is able to offer women with gynecologic cancers the optimal treatment in the most appropriate and desired setting. Since moving to Alaska in 2010, she has become the highest volume robotic surgeon in the state.

Education

Dr. Mayer Hope is a graduate of Stanford University (B.A. in Economics, 1992), completed her Masters at Antioch University in Ohio (Intercultural Relations, 1997) and received her MD from State University of New York, Brooklyn in 2003 with honors. She completed her postgraduate training at New York University Medical Center including a 4-year residency in Obstetrics and Gynecology, where she served as administrative chief in 2007 followed by a 3-year fellowship in Gynecologic Oncology. She is board certified in both Obstetrics and Gynecology (2009) and Gynecologic Oncology(2011) through the American Board of Obstetrics and Gynecology.

Interests

Dr. Joanie Mayer Hope is dedicated to supporting women with gyn cancers and raising awareness about women’s health issues. In 2012, she founded Let Every Woman Know- Alaska, a non-profit organization dedicated to raising awareness about gyn cancers throughout the state.
She is also a mother, an athlete, and passionate about music. Dr. Hope is lead singer in the nationally recognized rock band, No Evidence of Disease (N.E.D.) that consists of six (6) Gyn Oncologists on a mission to bring attention to and promote awareness of gyn cancers. 
N.E.D. tours nationally and is the subject of a feature length documentary titled N.E.D. produced by Spark Media and to be released nationally in 2014.

For more detail, please follow the links:

The band, N.E.D (No Evidence of Disease) www.nedtheband.com
The movie, No Evidence of Disease www.nedthemovie.com
Let Every Woman Know Alaska www.leteverywomanknow.org

Publications

Hope JM, Nagarsheth NN. Music and Medicine, Music and Cancer Healing. Jones & Bartlett, November 2009; Chapter 10: 110, Chapter 11: 136.

Hope JM, Long K, Kudla M, Arslan A, Tsymbal T, Strok I, Timor Tritsch E. Three dimensional Power Doppler Angiography of Cyclical Ovarian Blood Flow, Journal of Ultrasound in Medicine, J Ultrasound Med. Aug 2009 28:1043-1052

Hope JM, Blank SV. Current status of maintenance therapy for advanced ovarian cancer. International Journal of Women’s Health August 2009; 1: 173-180. Published online 2010 August 9. PMCID: PMC2971701

Whyte JS, Gil OD, Hope JM, Pua T, Fishman DA. LPA- induced time dependent modulation of coflin phosphorylation promotes stimulation of migration and invasion in ovarian carcinoma cells. Gynecologic Oncology. Volume 112, Issue 1, January 2009, Pages 215-223.

Hope JM, Pothuri BP. The role of surgery in palliative gynecologic cancer cases. The Oncologist 2013; 18:73-79; first published on January 8, 2013; doi:10.1634/theoncologist. 2012-0328.

Hope JM, Long K, Pua T, Goldman N. Primary Presentation of Cervix Cancer in the Distal Femur: A Case Report and Literature Review. International Journal of Gynecological Cancer. August 2009 (In Submission)

Hope JM, Wang FQ, Whyte JS, Ariztia E, Abdalla W, Long K, Fishman DA. LPA Receptor 2 Mediates LPA-Induced Endometrial Cancer Invasion. Gynecologic Oncology. Jan 2009; 112(1):215-23.

Devine KM, Smicun Y, Hope JM, Fishman DA. S1P induced changes in Ovarian Cancer Cell Proteolysis, Invasion, and Attachment are Mediated by Gi and Rac, Gynecologic Oncology. Aug 2008;110(2):237-45.

Kudla M, Timor-Tritsch I, Hope JM, Monteagudo A, Popiolek D, Monda S, Lee CJ, Arslan AA. Spherical Tissue Sampling in 3-Dimensional Power Doppler Angiography, Journal of Ultrasound in Medicine, March 2008; 27: 425-433.

Gil OD, Lee C, Ariztia EV, Wang FQ, Smith PJ, Hope JM, Fishman DA. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in a uPA dependent manner, Gynecologic Oncology, Jan 2008;108: 361-369

Hope JM, Petignat P, Blank SV, Bruchim I. Advancing Women’s Cancer Care: Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Gynakologisch-Geburtshilfliche Rundschau. 2006; 46(4):214-7

Hope JM, Lugassy D, Meyer R, Jeanty F, Myers S, Jones S, Bradley J, Mitchell R, Cramer E. Bringing Multicultural & Interdisciplinary Team-Building to Healthcare Education: The Downstate Team Building Initiative. Academic Medicine. 2005; 80(1): 74-83.